Syngene International Limited has informed the Exchange regarding Notice of Postal Ballot
SYNGENE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Syngene International Limited is seeking shareholder approval via postal ballot for appointing Ms. Kiran Mazumdar-Shaw as Executive Chairperson (Key Managerial Personnel) effective April 1, 2026, changing her current Non-Executive role. The proposed remuneration is Rs. 4 crores per annum (Rs. 33.33 lakhs monthly) for a 5-year tenure till March 31, 2031. At 73 years old, her appointment requires special shareholder approval under Schedule V of the Companies Act. She currently draws Rs. 7.10 million as sitting fees and commission. The company posted revenue of Rs. 34,907 million and PAT of Rs. 3,049 million for FY 2025-26. Remote e-voting runs from May 21, 2026 to June 19, 2026.
This change gives Ms. Mazumdar-Shaw, the company's founder and a major promoter holding 15.68% beneficial ownership, a more hands-on operational role. Shareholders should approve this as it formalizes her active involvement, though her dual executive roles at both Syngene and Biocon may attract regulatory scrutiny.